濟生醫藥生技股份有限公司
濟生醫藥生技股份有限公司（Chi Sheng Pharma & Biotech Co., Ltd.）製造銷售西藥、醫材、及營養品。產品涵蓋抗生素、氨基酸、血液透析濃縮液及外用生理食鹽水。此外提供醫美保養品及獸藥。公司成立於 1962 年，總部位於台灣新竹。
該股 RSI(6) 為 39.9，處於中性區間，短線無明顯超買超賣訊號。股價站上120日均線，跌破5日、20日、60日均線。短中期均線呈空頭排列，趨勢偏空。KD 指標中性（K=52.2）；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 08-10 | +19 | 0 | +2 | +21 |
| 08-07 | -1 | 0 | 0 | -1 |
| 08-06 | -5 | 0 | 0 | -5 |
| 08-05 | -1 | 0 | 0 | -1 |
| 08-04 | +3 | 0 | 0 | +3 |
| 08-03 | +4 | 0 | +6 | +9 |
| 07-31 | -2 | 0 | 0 | -2 |
| 07-30 | -10 | 0 | 0 | -10 |
| 07-29 | -12 | 0 | 0 | -12 |
| 07-28 | -2 | 0 | +1 | -2 |
| 07-27 | -2 | 0 | 0 | -2 |
| 07-24 | -1 | 0 | 0 | -1 |
| 07-23 | -2 | 0 | 0 | -2 |
| 07-22 | +2 | 0 | 0 | +2 |
| 07-21 | +4 | 0 | 0 | +4 |
| 07-20 | -2 | 0 | 0 | -2 |
| 07-17 | -8 | 0 | 0 | -8 |
| 07-16 | +3 | 0 | 0 | +3 |
| 07-15 | +5 | 0 | +1 | +5 |
| 07-14 | +9 | 0 | 0 | +9 |
| 07-13 | -8 | 0 | 0 | -8 |
| 07-09 | -1 | 0 | 0 | -1 |
| 07-08 | +4 | 0 | 0 | +4 |
| 07-07 | -13 | 0 | 0 | -13 |
| 07-06 | +2 | 0 | 0 | +2 |
| 07-03 | +27 | 0 | +2 | +27 |
| 07-02 | +21 | 0 | 0 | +21 |
| 07-01 | +2 | 0 | 0 | +2 |
| 06-30 | 0 | 0 | 0 | 0 |
| 06-29 | -6 | 0 | 0 | -6 |
| 06-26 | -14 | 0 | 0 | -14 |
| 06-25 | +29 | 0 | 0 | +20 |
| 06-24 | -4 | 0 | 0 | -4 |
| 06-23 | +4 | 0 | 0 | +4 |
| 06-22 | -21 | 0 | 0 | -21 |
| 06-18 | 0 | 0 | 0 | 0 |
| 06-17 | -5 | 0 | 0 | -5 |
| 06-15 | 0 | 0 | 0 | 0 |
| 06-12 | -1 | 0 | 0 | -1 |
| 06-11 | -3 | 0 | 0 | -3 |
| 06-10 | -2 | 0 | 0 | -2 |
| 06-09 | +5 | 0 | 0 | +5 |
| 06-08 | -3 | 0 | 0 | -3 |
| 06-05 | -1 | 0 | 0 | -1 |
| 06-04 | +10 | 0 | 0 | +10 |
| 06-03 | +52 | 0 | 0 | +52 |
| 06-02 | +2 | 0 | 0 | +2 |
| 06-01 | -1 | 0 | 0 | -1 |
| 05-29 | +3 | 0 | 0 | +3 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/04 | 1.27 億 | +7.6% | +6.5% |
| 2026/03 | 1.18 億 | +12.8% | +5.1% |
| 2026/02 | 1.05 億 | -21.2% | +5.9% |
| 2026/01 | 1.33 億 | +11.3% | +23.7% |
| 2025/12 | 1.20 億 | +3.7% | -0.9% |
| 2025/11 | 1.15 億 | +3.2% | +6.3% |
| 2025/10 | 1.12 億 | +0.5% | +9.5% |
| 2025/09 | 1.11 億 | +0.6% | +19.0% |
| 2025/08 | 1.11 億 | -8.1% | +16.9% |
| 2025/07 | 1.20 億 | -2.7% | +25.1% |
| 2025/06 | 1.24 億 | -0.7% | +37.9% |
| 2025/05 | 1.25 億 | - | +23.9% |